Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort study
血浆或组织证实存在EGFR突变的非小细胞肺癌患者接受拉泽替尼治疗后，血浆EGFR T790M和ctDNA在转移部位脱落的临床意义：一项前瞻性多中心队列研究
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-aw-1216
Kim, Min Jee; Jung, Junghee; Ji, Wonjun; Choi, Chang-Min; Kim, Seung Joon; Cho, Hyung Jun; Hwang, Yong Gi; Kim, Eun Young; Lee, Shin Yup; Yoo, Seung Soo; Choi, Sunha; Oh, In-Jae; Kim, Young-Chul; Park, Chul-Kyu; Yoon, Seong Hoon; Kim, Yun Seong; Kim, Mi-Hyun; Lee, Min Ki; Eom, Jung Seop; Kim, Soo Han; Lee, Jeong Eun; Chung, Chaeuk; Yeo, Chang Dong; Lee, Sang Haak; Lee, Jae Cheol
